Advancing precision cardio-oncology: multimodal surveillance and stratified management of immunotherapy-induced cardiovascular toxicity. (PubMed, Front Cardiovasc Med) - Oct 4, 2026 - "High-dose systemic corticosteroids remain the first-line intervention for symptomatic ICI-associated myocarditis, with targeted therapies like abatacept and ruxolitinib showing promise for steroid-refractory cases. Ultimately, proactive risk factor assessment and multidisciplinary cardio-oncology surveillance are imperative to mitigate acute toxicities and long-term atherosclerotic risks, ensuring optimal patient outcomes."
IO biomarker • Journal • Review • Atherosclerosis • Cardiovascular • Congestive Heart Failure • Heart Failure • Inflammation • Oncology • CD8
|